Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 233-899-5 | CAS number: 10421-48-4
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vivo
Administrative data
- Endpoint:
- in vivo mammalian somatic cell study: cytogenicity / erythrocyte micronucleus
- Remarks:
- Type of genotoxicity: chromosome aberration
- Type of information:
- migrated information: read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- weight of evidence
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Research paper. Study well documented meeting generally accepted scientific principles.
Data source
Reference
- Reference Type:
- publication
- Title:
- Nuclear aberrations and micronuclei induction in the digestive tract of mice treated with different iron salts.
- Author:
- Bianchini F, Caderni G, Dolara P, Tanagnelli E
- Year:
- 1 988
- Bibliographic source:
- J. App. Tox. 8(3): 179-183
Materials and methods
Test guideline
- Qualifier:
- no guideline followed
- Principles of method if other than guideline:
- Method: other: Wargovich et al, J Natl Cancer Inst 71, 133-137 (1983)
- GLP compliance:
- not specified
- Type of assay:
- micronucleus assay
Test material
- Reference substance name:
- Iron sulphate
- EC Number:
- 231-753-5
- EC Name:
- Iron sulphate
- Cas Number:
- 7720-78-7
- IUPAC Name:
- iron(2+) sulfate
- Test material form:
- solid: crystalline
- Details on test material:
- Test substance obtained from Merck and reportedly containing ca 20% Fe.
The material tested was the heptahydrate of Ferrous sulphate CAS No 7782-63-0 FeS04.7H20 but this does not affect the chemical species available to the test organisms.
Constituent 1
Test animals
- Species:
- mouse
- Strain:
- other: C57BL/6J
- Sex:
- female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles river, Calco, Como Italy
- Age at study initiation: no information
- Weight at study initiation: 17-18 g
- Assigned to test groups randomly: no information
- Fasting period before study: 12 h, or not fasted
- Diet (e.g. ad libitum): ad libitum for non-fasting animals
- Water (e.g. ad libitum): ad libitum (after treatment)
Administration / exposure
- Route of administration:
- other: oral gavage or intrarectal
- Vehicle:
- - Vehicle(s)/solvent(s) used: saline
- Amount of vehicle (if gavage or dermal): 0.2 ml - Details on exposure:
- PREPARATION OF DOSING SOLUTIONS: no details
- Duration of treatment / exposure:
- 24 hours
- Frequency of treatment:
- Single treatment
- Post exposure period:
- 24 hours
Doses / concentrations
- Remarks:
- Doses / Concentrations:
2, 6.5 and 13 mg Fe/kg
Basis:
- No. of animals per sex per dose:
- 4-9 female animals per dose
- Control animals:
- yes
- Positive control(s):
- - 2-amino-3-methylimidazo(4,5-f)quinoline) (IQ)
- Justification for choice of positive control(s): IQ is a genotoxic chemical with specific intestinal action.
- Route of administration: orally to non-fasting mice
- Doses / concentrations: 100 and 200 mg/kg bw
Examinations
- Tissues and cell types examined:
- Samples of forestomach, duodenum and colon were taken following oral administration and colon samples after intrarectal administration
- Details of tissue and slide preparation:
- CRITERIA FOR DOSE SELECTION: The lowest dose tested was equivalent to a therapeutic dose in iron deficiency anaemia.
DETAILS OF SLIDE PREPARATION: colon and duodenum where opened longitudinally and rolled. The forestomach was excised. Specimens were fixed in 10% buffered formalin and processed for histology. Slides with 5 micron thick paraffin sections were stained with Feulgen-fast green.
METHOD OF ANALYSIS:
Slides were examined and scored for a) micronuclei defined as nuclear fragments not larger than ¼ -1/3 of the diameter of the primary nucleus b) nuclear aberrations comprised of micronuclei, pyknotic nuclei, cytolysosomes and disintegrated nuclei. The forestomach was analysed by observing around 400 mucosal cells per animal. Mucosal cells lining 20 crypts for colon and 5 crypts for duodenum were analysed per animal beginning from the anal end of the colon and the pyloric end of the duodenum. - Evaluation criteria:
- Evaluation criteria are not described.
- Statistics:
- No statistical evaluation was described.
Results and discussion
Test results
- Sex:
- female
- Genotoxicity:
- negative
- Toxicity:
- yes
- Vehicle controls validity:
- valid
- Negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Additional information on results:
- The reference compound IQ caused an increase of nuclear aberrations and micronuclei, results being presented for effects in the colon. Ferrous sulphate did not significantly increase the incidence of micronuclei in the stomach, duodenum or colon following oral
administration to fasting or non-fasting mice. In the colon nuclear aberrations indicating toxicity were increased in fasting and non-fasting mice receiving oral ferrous sulphate. Following intrarectal administration ferrous sulfate showed slight toxicity to the colon producing a slight but statistically
significant (p<0.01) increase in micronuclei and in chromosome aberrations. The authors consider that the iron salts do not appear to have a significant genotoxic effect on the gastrointestinal tract and that the toxic effects are
due to generalized toxicity rather than a genotoxic effect.
Any other information on results incl. tables
The reference compound IQ caused an increase of nuclear aberrations and
micronuclei, results being presented for effects in the colon. Ferrous
sulphate did not significantly increase the incidence of micronuclei in
the stomach, duodenum or colon following oral administration to fasting
or non-fasting mice. In the colon nuclear aberrations indicating
toxicity were increased in fasting and non-fasting mice receiving oral
ferrous sulphate.
Following intrarectal administration ferrous sulfate showed
slight toxicity to the colon producing a slight but statistically
significant (p<0.01) increase in micronuclei and in chromosome
aberrations.
The authors consider that the iron salts do not appear to have a
significant genotoxic effect on the gastrointestinal tract and that the
toxic effects are due to generalized toxicity rather than a
genotoxic effect.
Applicant's summary and conclusion
- Conclusions:
- Interpretation of results (migrated information): negative
Ferrous sulphate is not considered to have a significant genotoxic effect on the mouse gastrointestinal tract as measured by induction of micronuclei. An increased incidence of nuclear aberrations was considered evidence of general toxicity rather than mutagenic activity. - Executive summary:
This study was undertaken to assess the effects of iron status on the gastrointestinal tract using the nuclear aberrations assay of Wargovich, Medline and Bruce, 1983.
The current authors interpreted the results by differentiating between micronuclei and nuclear aberrations considering that micronuclei are a specific sign of genetic damage while nuclear aberrations are more unspecific effects related to cellular toxicity. This was because nuclear aberrations may also be associated with substances acting through non-genotoxic mechanisms.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.